UK's Sovereign AI Fund Bets £500 Million on Homegrown Drug Discovery

The structural consequence of the Sovereign AI Fund is not funding — it is selection. When a government deploys £500 million with explicit criteria favoring drug discovery and supercomputing, it is not waiting for the scientific community to identify which AI approaches prove out. It is choosing which companies and which methods become the ones that prove out, by giving them the resources to outpace rivals.